BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 19200200)

  • 1. Alopecia in congenital hidrotic ectodermal dysplasia responding to treatment with a combination of topical minoxidil and tretinoin.
    Melkote S; Dhurat RS; Palav A; Jerajani HR
    Int J Dermatol; 2009 Feb; 48(2):184-5. PubMed ID: 19200200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tretinoin for hair growth promotion.
    Bazzano GS; Terezakis N; Galen W
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):880-3, 890-3. PubMed ID: 3771854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice?
    Mapar MA; Omidian M
    J Dermatolog Treat; 2007; 18(5):268-70. PubMed ID: 17917938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic use of topical minoxidil.
    DeVillez RL
    Dermatol Clin; 1990 Apr; 8(2):367-75. PubMed ID: 2191807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
    Koperski JA; Orenberg EK; Wilkinson DI
    Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of minoxidil high extra combination therapy in patients with androgenetic alopecia.
    Pazoki-Toroudi H; Babakoohi S; Nilforoushzadeh MA; Nassiri-Kashani M; Shizarpour M; Ajami M; Habibey R; Sadr B; Rashighi-Firoozabadi M; Firooz A
    Skinmed; 2012; 10(5):276-82. PubMed ID: 23163069
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypotrichosis and nail dysplasia: a novel hidrotic ectodermal dysplasia.
    Harrison S; Sinclair R
    Australas J Dermatol; 2004 May; 45(2):103-5. PubMed ID: 15068456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
    Sharma A; Goren A; Dhurat R; Agrawal S; Sinclair R; Trüeb RM; Vañó-Galván S; Chen G; Tan Y; Kovacevic M; Situm M; McCoy J
    Dermatol Ther; 2019 May; 32(3):e12915. PubMed ID: 30974011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical minoxidil dose-response effect in alopecia areata.
    Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
    Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of androgenic alopecia with minoxidil].
    Kohl PK
    Hautarzt; 1993 Feb; 44(2):114. PubMed ID: 8449692
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of oral minoxidil in the treatment of alopecia areata.
    Fiedler-Weiss VC; Rumsfield J; Buys CM; West DP; Wendrow A
    Arch Dermatol; 1987 Nov; 123(11):1488-90. PubMed ID: 3674909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical minoxidil therapy for hair regrowth.
    Rumsfield JA; West DP; Fiedler-Weiss VC
    Clin Pharm; 1987 May; 6(5):386-92. PubMed ID: 3311578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
    Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
    Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical minoxidil for hair regrowth.
    Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
    J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
    Tosti A; Iorizzo M; Vincenzi C
    Arch Dermatol; 2003 Sep; 139(9):1221-2. PubMed ID: 12975176
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical minoxidil: review of efficacy and safety.
    Katz HI
    Cutis; 1989 Jan; 43(1):94-8. PubMed ID: 2644080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical minoxidil treatment for congenital alopecia in hypohidrotic ectodermal dysplasia.
    Lee HE; Chang IK; Im M; Seo YJ; Lee JH; Lee Y
    J Am Acad Dermatol; 2013 Apr; 68(4):e139-e140. PubMed ID: 23522427
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical minoxidil therapy for hereditary male pattern alopecia.
    Roenigk HH; Pepper E; Kuruvilla S
    Cutis; 1987 Apr; 39(4):337-42. PubMed ID: 3556042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.